These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 12800293)
41. Melanoma screening: A plan for improving early detection. Shellenberger R; Nabhan M; Kakaraparthi S Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192 [TBL] [Abstract][Full Text] [Related]
45. Societal cost of skin cancer in Sweden in 2005. Tinghög G; Carlsson P; Synnerstad I; Rosdahl I Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884 [TBL] [Abstract][Full Text] [Related]
47. [Diagnosis of malignant melanomas. I. Clinical picture and epidemiology of malignant melanomas at the Dermatological Clinic of the Medical Academy Magdeburg]. Kühne KH; Sochor H Dermatol Monatsschr; 1978 Feb; 164(2):108-13. PubMed ID: 648687 [No Abstract] [Full Text] [Related]
48. The result of management of seventy consecutive cases of malignant melanoma from 1939 to 1972 in the Charleston General Hospital, Charleston, West Virginia. Lee HS W V Med J; 1974 May; 70(5):109-18. PubMed ID: 4527021 [No Abstract] [Full Text] [Related]
49. Validity of self-reported skin screening histories. Aitken JF; Youl PH; Janda M; Elwood M; Ring IT; Lowe JB; Firman DW Am J Epidemiol; 2004 Jun; 159(11):1098-105. PubMed ID: 15155295 [TBL] [Abstract][Full Text] [Related]
50. Comparability of skin screening histories obtained by telephone interviews and mailed questionnaires: a randomized crossover study. Aitken JF; Youl PH; Janda M; Elwood M; Ring IT; Lowe JB Am J Epidemiol; 2004 Sep; 160(6):598-604. PubMed ID: 15353421 [TBL] [Abstract][Full Text] [Related]
51. Melanoma in situ in Puerto Rico: clinical characteristics and detection patterns. Muñoz C; Vázquez-Botet M P R Health Sci J; 2004 Sep; 23(3):179-82. PubMed ID: 15631171 [TBL] [Abstract][Full Text] [Related]
52. Malignant melanoma: how error amplification by screening creates spurious disease. Shuster S Br J Dermatol; 2009 Nov; 161(5):977-9. PubMed ID: 19785614 [TBL] [Abstract][Full Text] [Related]
53. [Secondary prevention of malignant melanoma]. Eichmann A Ther Umsch; 1999 Jun; 56(6):290-1. PubMed ID: 10420808 [TBL] [Abstract][Full Text] [Related]
54. [Melanoma from the dermatological viewpoint]. Braun W Dtsch Gesundheitsw; 1970 Jan; 25(4):155-8. PubMed ID: 5447191 [No Abstract] [Full Text] [Related]
55. The value of screening in melanoma. Stratigos AJ; Katsambas AD Clin Dermatol; 2009; 27(1):10-25. PubMed ID: 19095150 [TBL] [Abstract][Full Text] [Related]
56. Do centralised skin screening clinics increase participation in melanoma screening (Australia)? Janda M; Lowe JB; Elwood M; Ring IT; Youl PH; Aitken JF Cancer Causes Control; 2006 Mar; 17(2):161-8. PubMed ID: 16425094 [TBL] [Abstract][Full Text] [Related]
57. [Statistical aspects on malignant melanoma in Sweden]. Malec E Nord Med; 1970 Oct; 84(42):1340. PubMed ID: 5479540 [No Abstract] [Full Text] [Related]
59. Malignant melanoma of the skin - not a sunshine story! Hallberg O; Johansson O Med Sci Monit; 2004 Jul; 10(7):CR336-40. PubMed ID: 15232509 [TBL] [Abstract][Full Text] [Related]
60. [Skin cancer screening program in the population of Bydgoszcz]. Mierzwa T; Zegarski W; Placek W; Zegarska B Wiad Lek; 2004; 57 Suppl 1():211-4. PubMed ID: 15884241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]